I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The impact of proton-pump inhibitors administered with tyro..:
Buti, Sebastiano
;
Tommasi, Chiara
;
Scartabellati, Giulia
...
Anti-Cancer Drugs. 34 (2022) 1 - p. 178-186 , 2022
Link:
https://doi.org/10.1097/cad.0000000000001356
RT Journal T1
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1097_cad.0000000000001356&Exemplar=1&LAN=DE A1 Buti, Sebastiano A1 Tommasi, Chiara A1 Scartabellati, Giulia A1 De Giorgi, Ugo A1 Brighi, Nicole A1 Rebuzzi, Sara Elena A1 Puglisi, Silvia A1 Caffo, Orazio A1 Kinspergher, Stefania A1 Mennitto, Alessia A1 Cattrini, Carlo A1 Santoni, Matteo A1 Verzoni, Elena A1 Rametta, Alessandro A1 Stellato, Marco A1 Malgeri, Andrea A1 Roviello, Giandomenico A1 de Filippo, Massimo A1 Cortellini, Alessio A1 Bersanelli, Melissa PB Ovid Technologies (Wolters Kluwer Health) YR 2022 SN 0959-4973 JF Anti-Cancer Drugs VO 34 IS 1 SP 178 OP 186 LK http://dx.doi.org/https://doi.org/10.1097/cad.0000000000001356 DO https://doi.org/10.1097/cad.0000000000001356 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)